These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30345657)

  • 1. The Development of a Weighted Index to Optimise Compound Libraries for High Throughput Screening.
    Eurtivong C; Reynisson J
    Mol Inform; 2019 Mar; 38(3):e1800068. PubMed ID: 30345657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR modeling of imbalanced high-throughput screening data in PubChem.
    Zakharov AV; Peach ML; Sitzmann M; Nicklaus MC
    J Chem Inf Model; 2014 Mar; 54(3):705-12. PubMed ID: 24524735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodiversity of small molecules--a new perspective in screening set selection.
    Petrone PM; Wassermann AM; Lounkine E; Kutchukian P; Simms B; Jenkins J; Selzer P; Glick M
    Drug Discov Today; 2013 Jul; 18(13-14):674-80. PubMed ID: 23454345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical Machine Learning: Virtual High-Throughput Screens Identifying Promising and Economical Small Molecule Inhibitors of Complement Factor C1s.
    Chen JJ; Schmucker LN; Visco DP
    Biomolecules; 2018 May; 8(2):. PubMed ID: 29735903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hit-to-Lead: Hit Validation and Assessment.
    Hevener KE; Pesavento R; Ren J; Lee H; Ratia K; Johnson ME
    Methods Enzymol; 2018; 610():265-309. PubMed ID: 30390802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locating sweet spots for screening hits and evaluating pan-assay interference filters from the performance analysis of two lead-like libraries.
    Mok NY; Maxe S; Brenk R
    J Chem Inf Model; 2013 Mar; 53(3):534-44. PubMed ID: 23451880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAIN(S) relievers for medicinal chemists: how computational methods can assist in hit evaluation.
    Stork C; Kirchmair J
    Future Med Chem; 2018 Jul; 10(13):1533-1535. PubMed ID: 29956552
    [No Abstract]   [Full Text] [Related]  

  • 8. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB; DeCaprio D
    Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files.
    Bell AS; Bradley J; Everett JR; Loesel J; McLoughlin D; Mills J; Peakman MC; Sharp RE; Williams C; Zhu H
    Mol Divers; 2016 Nov; 20(4):789-803. PubMed ID: 27631533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data-driven approaches used for compound library design, hit triage and bioactivity modeling in high-throughput screening.
    Paricharak S; Méndez-Lucio O; Chavan Ravindranath A; Bender A; IJzerman AP; van Westen GJP
    Brief Bioinform; 2018 Mar; 19(2):277-285. PubMed ID: 27789427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal HTS Fingerprint Definitions by Using a Desirability Function and a Genetic Algorithm.
    Cortes Cabrera A; Petrone PM
    J Chem Inf Model; 2018 Mar; 58(3):641-646. PubMed ID: 29425455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR classification model for antibacterial compounds and its use in virtual screening.
    Singh N; Chaudhury S; Liu R; AbdulHameed MD; Tawa G; Wallqvist A
    J Chem Inf Model; 2012 Oct; 52(10):2559-69. PubMed ID: 23013546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space.
    Koutsoukas A; Paricharak S; Galloway WR; Spring DR; Ijzerman AP; Glen RC; Marcus D; Bender A
    J Chem Inf Model; 2014 Jan; 54(1):230-42. PubMed ID: 24289493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Analysis of Different Components of a High-Throughput Screening Library.
    Saha A; Varghese T; Liu A; Allen SJ; Mirzadegan T; Hack MD
    J Chem Inf Model; 2018 Oct; 58(10):2057-2068. PubMed ID: 30204440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of Strategic Small-Scale Targeted Screening.
    Sharlow ER
    Assay Drug Dev Technol; 2016 Aug; 14(6):329-32. PubMed ID: 27341343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast and Efficient Fragment-Based Lead Generation by Fully Automated Processing and Analysis of Ligand-Observed NMR Binding Data.
    Peng C; Frommlet A; Perez M; Cobas C; Blechschmidt A; Dominguez S; Lingel A
    J Med Chem; 2016 Apr; 59(7):3303-10. PubMed ID: 26964888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing the delivery of next generation therapeutics from high throughput screening libraries.
    Wigglesworth MJ; Murray DC; Blackett CJ; Kossenjans M; Nissink JW
    Curr Opin Chem Biol; 2015 Jun; 26():104-10. PubMed ID: 25909818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPCR profiling: from hits to leads and from genotype to phenotype.
    Cvijic ME; Sum CS; Alt A; Zhang L
    Drug Discov Today Technol; 2015 Nov; 18():30-7. PubMed ID: 26723890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Qualified Success: Discovery of a New Series of ATAD2 Bromodomain Inhibitors with a Novel Binding Mode Using High-Throughput Screening and Hit Qualification.
    Bamborough P; Chung CW; Demont EH; Bridges AM; Craggs PD; Dixon DP; Francis P; Furze RC; Grandi P; Jones EJ; Karamshi B; Locke K; Lucas SCC; Michon AM; Mitchell DJ; Pogány P; Prinjha RK; Rau C; Roa AM; Roberts AD; Sheppard RJ; Watson RJ
    J Med Chem; 2019 Aug; 62(16):7506-7525. PubMed ID: 31398032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reaching for the bright StARs in chemical space.
    Medina-Franco JL; Naveja JJ; López-López E
    Drug Discov Today; 2019 Nov; 24(11):2162-2169. PubMed ID: 31557448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.